Clinical trials
Lung Neoplasms trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Recruiting | 14 |
| Active, not recruiting | 6 |
| Unknown status | 4 |
| Terminated | 3 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 10 |
| National University Hospital, Singapore | 6 |
| Boehringer Ingelheim | 3 |
| Bristol-Myers Squibb | 3 |
| Hoffmann-La Roche | 3 |
| National Cancer Centre, Singapore | 3 |
| Singapore General Hospital | 3 |
| Amgen | 2 |
| Revolution Medicines, Inc. | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 61 |
| Carcinoma, Non-Small-Cell Lung | 41 |
| Neoplasms | 11 |
| Adenocarcinoma of Lung | 8 |
| Carcinoma | 8 |
| Lung Diseases | 8 |
| Bronchial Neoplasms | 7 |
| Colonic Neoplasms | 7 |
| Neoplasms by Site | 7 |
| Respiratory Tract Diseases | 7 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.